Back to EMR overview

Emerson Electric Co. (EMR): The Software-Led Pivot Is Finished

Published August 25, 202627 min read·TickerFile Research · EMERSON ELECTRIC CO (EMR)
ShareXLinkedIn

Emerson Electric spent the better part of a decade remaking itself. The Climate Technologies divestiture in 2023, the consolidation of National Instruments into Test & Measurement, and the March 2025 take-private of AspenTech for roughly $7.2 billion together transformed a diversified industrial conglomerate into a focused automation franchise. With the third quarter of fiscal 2026, management is signaling that the transformation phase is over. Net sales of $4,873 million were up 7 percent year over year, diluted earnings per share from continuing operations of $1.28 were up 24 percent, and the company raised the high end of full-year guidance while narrowing the range to roughly $4.89 in GAAP earnings and approximately $6.55 in adjusted earnings. The "new Emerson" is now a three-segment automation pure-play with $9.6 billion of remaining performance obligations, a Test & Measurement business compounding at low double digits, and a software business whose economics increasingly drive the consolidated margin profile.

The strongest evidence supporting the new thesis is the segment mix shift. Software & Systems, which combines Control Systems & Software with Test & Measurement, generated 34 percent of third quarter sales but 50 percent of segment earnings, and the Test & Measurement subsegment grew underlying sales 23 percent on aerospace and defense and semiconductor demand. Intelligent Devices, the largest group by revenue, expanded adjusted EBITA margin 2.4 percentage points even as restructuring costs more than doubled. Backlog at $9.6 billion is a near-record for the post-divestiture company, providing a multi-quarter visibility cushion that did not exist during the early years of the pandemic-era industrial cycle.

The strongest counterargument is that the headline EPS print benefited from a non-recurring IEEPA tariff refund of $82 million ($0.11 per share), a lower restructuring run-rate comparison in some line items, and a one-percentage-point tax tailwind. Strip those out and the underlying earnings growth rate is closer to mid-teens, which is still attractive but materially below the reported 24 percent. The new segment structure also makes historical comparisons noisy: management reorganized into five subsegments in November 2025 and prior-year figures were reclassified, so investors evaluating trend lines are working with a re-stated base. The most important forward variable is whether Test & Measurement's 23 percent growth normalizes or whether the aerospace, defense, and semiconductor capex cycle that drove it proves durable.